New research has shown that medical cannabis may effectively manage fibromyalgia and associated symptoms of depression and anxiety.
MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) said the study was conducted by its subsidiary Harvest Medicine.
Titled "Self-Reported Effects of Illness Severity, Depression and Anxiety in Fibromyalgia Patients: A Large Retrospective Case Series," the study was published in the peer-reviewed American Journal of Endocannabinoid Medicine.
The Study And Key Findings
- The research included data from 805 patients who indicated fibromyalgia, a pain disorder characterized by chronic widespread pain, non-restorative sleep, fatigue, and impaired cognition, as a primary reason for seeking medical cannabis and had a minimum of one follow-up assessment.
- The majority of patients (76.1%) reported using …